There is no maximum time limit for taking Ozempic. The FDA label does not specify a duration cap, and because it treats chronic conditions like type 2 diabetes, most people stay on it indefinitely as long as it continues working and they tolerate it well. The more practical question is whether you’ll want to stop, whether your insurance will keep covering it, and what happens to your body if you do.
Why Ozempic Is Designed for Long-Term Use
Ozempic (semaglutide) is FDA-approved to improve blood sugar control in adults with type 2 diabetes, reduce the risk of major cardiovascular events like heart attack and stroke, and protect kidney function in people with type 2 diabetes and chronic kidney disease. All three of these are ongoing conditions, not problems you treat once and move on from. The medication works by mimicking a hormone that regulates blood sugar and appetite, and those effects only last as long as you keep taking it.
The American Diabetes Association’s 2025 guidelines reinforce this approach. They recommend continuing weight loss medications even after you’ve reached your goals, both to maintain results and to reduce cardiovascular risk. In clinical trials, patients have been studied on semaglutide for up to two years, and many real-world patients have been on it considerably longer without a prescribed stopping point.
What Happens When You Stop
This is the part most people searching this question really need to understand. Weight regain after stopping semaglutide is not a possibility; it’s the expected outcome. A 2025 systematic review published in The BMJ analyzed data from thousands of participants and found that people regain weight at a rate of roughly 0.8 kg (about 1.8 pounds) per month after stopping newer, more effective versions of these drugs. Within the first year off medication, the average person regained about 9.9 kg (roughly 22 pounds).
The same analysis projected that people return to their baseline weight, meaning the weight they started at before treatment, within about 1.5 years of stopping. This isn’t unique to semaglutide. It reflects the biology of obesity: the hormonal signals that drive hunger and fat storage reassert themselves once the medication is no longer suppressing them. Blood sugar control in people with type 2 diabetes follows a similar pattern, with levels typically rising again after discontinuation.
The Insurance Problem
Even though the medication is meant to be taken long-term, your insurance plan may not agree to cover it that way. Coverage varies dramatically between insurers, and some impose hard limits. The University of Michigan’s prescription drug plan, for example, caps coverage of GLP-1 drugs prescribed for weight loss at 24 one-month fills over a lifetime. That’s two years total, regardless of how well the medication is working.
Most plans also require prior authorization, which means your prescriber must document that you meet specific criteria, often including a minimum BMI, a diagnosis of type 2 diabetes, or evidence of a related condition. These authorizations typically need to be renewed every 6 to 12 months. If your health metrics improve significantly on the medication (lower A1C, lower BMI), some insurers may paradoxically decide you no longer qualify, even though stopping would reverse those improvements.
If you’re taking Ozempic specifically for type 2 diabetes rather than weight management alone, coverage tends to be more stable and less likely to carry lifetime limits. The distinction matters when your doctor submits the prescription.
Side Effects Over Time
The most common side effects, nausea, vomiting, and diarrhea, are typically worst during the dose escalation phase, the first several weeks when your dose is gradually increased. For most people, these settle down once the body adjusts to a stable maintenance dose. That’s why the standard dosing schedule starts low and increases over months.
Long-term safety data from clinical trials spanning up to two years is generally reassuring, but there are a few things worth knowing. The FDA label notes that in animal studies, semaglutide caused thyroid tumors in rodents at clinically relevant doses, and the risk increased with longer exposure. This hasn’t been confirmed in humans, but it’s why Ozempic carries a warning for people with a personal or family history of certain thyroid cancers. The label also notes that the long-term effects of semaglutide on diabetic eye disease complications haven’t been fully studied.
Staying on a Stable Dose
Ozempic comes in several dose levels: 0.25 mg, 0.5 mg, 1 mg, and 2 mg, all given as a once-weekly injection. The 0.25 mg dose is purely for the initial ramp-up period. Most people settle at 0.5 mg or 1 mg for diabetes management, with 2 mg available if more blood sugar or weight control is needed. Once you and your doctor identify the dose that works, that’s typically where you stay. There’s no need to keep increasing over time unless your condition changes.
Some people do find that the medication’s effects on appetite or blood sugar seem to plateau after a year or more. This doesn’t necessarily mean the drug has stopped working. It may mean you’ve reached a new set point where the medication is maintaining your results rather than producing further change. That maintenance effect is itself the reason to continue.
Planning for the Long Term
The realistic answer to “how long can you stay on Ozempic” is: as long as you need it, can tolerate it, and can access it. For people with type 2 diabetes, that often means years or decades. For people using it primarily for weight management, the biological reality of weight regain after stopping makes long-term use the most effective strategy, but insurance and cost (list price runs over $900 per month without coverage) can make that difficult to sustain.
If you’re considering stopping, either by choice or because of access issues, a gradual approach with close monitoring gives you the best chance of preserving some of the benefits. Building strong exercise and dietary habits while on the medication can help slow weight regain, though it won’t fully prevent it. The weight regain data makes one thing clear: the decision to start Ozempic is, for most people, a decision to stay on it.